Teva Pharmaceutical Industries, seeking to enhance a specialty drug portfolio, skeleton to acquire Cephalon Inc. for $6.8 billion.
Teva, that is formed in Israel, has a vast production plant in
Irvine. That plant resumed operation in Apr after shutting for a year
following a warning by a Food and Drug Administration over
Sales of Copaxone, used in a diagnosis of mixed sclerosis, constituted about 30%
Read Full Story